Abstract S-P467L mice expressing dominant negative Peroxisome Proliferator Activated
Receptor-γ selectively in vascular smooth muscle, exhibit impaired vasodilation, augmented …

S-P467L mice expressing dominant negative peroxisome proliferator-activated receptor-γ
selectively in vascular smooth muscle exhibit impaired vasodilation, augmented …

S-P467L mice expressing dominant negative peroxisome proliferator-activated receptor-γ
selectively in vascular smooth muscle exhibit impaired vasodilation, augmented …

Mice expressing dominant‐negative PPARG in vascular smooth muscle (S‐P467L)
exhibited vascular dysfunction, hypertension and tachycardia. We hypothesize that a high …

Peroxisome proliferator‐activated receptor‐gamma (PPARg) may play an important
protective role in the vasculature. We examined the hypothesis that selective interference …

Transgenic mice expressing a vascular muscle‐specific dominant negative mutant of
PPARG (S‐P467L) develop hypertension and aortic dysfunction, supporting a protective role …

Although peroxisome proliferator–activated receptor-γ (PPARγ) is thought to play a
protective role in the vasculature, its cell-specific effect, particularly in resistance vessels, is …

PPARγ is a ligand activated transcription factor expressed in vascular muscle and
endothelium. We previously reported that targeted expression of a dominant negative …

Peroxisome proliferator-activated receptor-γ (PPARγ), a member of the nuclear receptor
superfamily of ligand activated transcription factors, plays a critical role in adipogenesis and …

Angiotensin II (Ang II) plays a major role in vascular disease, including both large and small
vessel disease in brain. PPARγ is a ligand-activated nuclear receptor that exerts protective …